Clinical Trial Update: A Multicenter, Single-arm, Prospective Phase II Clinical Study of Epalrotokewali Combined With Eribulin, Anlotinib, and Radiotherapy for the Treatment of Patients With Advanced Soft Tissue Sarcoma. [Phase 2]

View source ↗

Summary

Phase II multicenter, single-arm trial evaluating Epalrotokewali combined with eribulin, anlotinib, and radiotherapy for advanced soft tissue sarcoma; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib (anlotinib)
• Epalrotokewali
• Eribulin (eribulin mesilate)

Snippet

Sponsor: Fudan University | Conditions: Soft Tissue Sarcoma (STS) | Phase 2 | Status: NOT_YET_RECRUITING